📋 About your medication
Bliv offers both compounded GLP-1 medications prepared by licensed compounding pharmacies, and access to branded GLP-1 medications manufactured by Novo Nordisk (Ozempic®, Wegovy®) and Eli Lilly (Mounjaro®, Zepbound®). The guidance in this article applies to GLP-1 therapy generally regardless of which medication you have been prescribed.
Plateaus are normal — and expected
If your weight loss has slowed or stopped, you have not failed, and your medication has not stopped working. Weight loss plateaus are a well-documented and predictable part of GLP-1 therapy — particularly around weeks 6–16 of treatment, and again after any recent dose increase or stabilization.
The body responds to sustained calorie reduction by adapting its metabolism. This is a survival mechanism, not a malfunction. Clinical trials for both semaglutide and tirzepatide show that patients continue losing weight over 12–18 months — but the rate is rarely linear.
What counts as a plateau vs. normal slowing
Your weight naturally fluctuates by 2–5 lbs day to day. A single week of no change is not a plateau. A true plateau is generally defined as four or more consecutive weeks of no measurable weight loss while taking your medication consistently and without major changes to your diet or activity.
Tip: Weigh yourself the same way every time — morning, after using the bathroom, before eating or drinking. Weekly weigh-ins are more informative than daily ones. Track a 4-week rolling trend, not individual days.
---
Common reasons a plateau develops
Dose adaptation
Your body recalibrates to appetite suppression at a given dose over time, making the effect feel less pronounced.
Caloric creep
As early side effects resolve, appetite partially returns. Portions gradually increase without patients noticing.
Muscle loss
Rapid weight loss without resistance training reduces muscle mass, lowering your resting metabolic rate.
Injection site issues
Repeated injection in the same spot causes lipodystrophy, which impairs how the medication is absorbed.
Inconsistent timing
Frequently shifting your injection day disrupts stable medication levels throughout the week.
Sleep and stress
Elevated cortisol from poor sleep or chronic stress directly inhibits the metabolic effects of GLP-1 therapy.
Alcohol is another often-overlooked factor. It is calorie-dense and is rarely counted as food intake — and GLP-1 therapy changes how many patients experience alcohol tolerance.
---
What you can do right now
1. Check your injection technique and site rotation. Review the article How to inject your GLP-1 medication and confirm you are rotating sites each week. Lipodystrophy is a surprisingly common and easily fixed cause of stalled progress.
2. Audit your eating patterns — not calories, quality. Are meals larger than they were 6 weeks ago? Are you grazing between meals? High-fat, high-calorie foods offset GLP-1's appetite effects even at smaller portions.
3. Increase protein intake. Aim for at least 0.7–1g of protein per pound of body weight daily. Protein preserves muscle mass during weight loss and extends satiety between meals.
4. Add resistance training. Even 2–3 sessions per week of bodyweight or light strength exercises meaningfully improves body composition and resting metabolic rate over time.
5. Lock in a consistent injection day. Pick one day each week and do not shift it. Consistency maintains stable medication levels.
6. Prioritize sleep. Seven or more hours consistently supports GLP-1's metabolic effects. Sleep deprivation directly elevates cortisol, which counteracts fat loss.
---
What progress actually looks like over time
Weeks 1–4: Fastest early loss, appetite suppression strongest
Weeks 6–16: First plateau window — very common, does not mean failure
Months 3–6: Renewed loss as dose escalates and habits consolidate
Months 12–18: 15–22%+ body weight loss in clinical trials at full dose
The patients who reach those outcomes are not the ones who never plateau — they are the ones who continue treatment through the plateaus.
When to contact your care team
If you have been on the same dose for 8 or more weeks, have worked through the steps above, and still see no movement, it may be time for a dose adjustment. Your Bliv provider can review your treatment history and determine whether escalating your dose is appropriate.
Book a nurse follow-up call — your nurse can review your dosing history, injection technique, and lifestyle factors, and coordinate with your provider if a dose change is warranted.
Book a nurse call (English): https://calendly.com/d/cv7x-j27-mqw/glp-1-nurse-follow-up-call
Book a nurse call (Spanish): https://calendly.com/d/csnq-7pm-pjg/spanish-glp-1-nurse-follow-up-call
Related articles: How to inject your GLP-1 medication · Side Effects & Safety Information · Can I Stay at My Current Dose? · How to Schedule a Nurse Follow-Up Call